Table 1.
Clinical Characteristics of HyperGEN Participants Free of Exclusions
| Clinical characteristic | Whites | Blacks | ||
|---|---|---|---|---|
| Males N=526 |
Females N=578 |
Males N=314 |
Females N=640 |
|
| Age, years | 52.5±14.1 | 53.1±12.8 | 46.3±13.3 | 47.6±13.3 |
| Coronary artery disease, n(%) | 50 (9.5) | 25 (4.3) | 25 (8.0) | 33 (5.2) |
| Hypertension, n(%) | 277 (52.7) | 299 (51.7) | 183(58.3) | 385 (60.2) |
| Diabetes, n(%) | 63 (12.0) | 78 (13.5) | 53 (16.9) | 131 (20.5) |
| Stroke, n(%) | 17 (3.2) | 15 (2.6) | 22 (7.1) | 25 (3.9) |
| Obesity, n(%) | 215 (40.9) | 255 (44.1) | 127 (40.4) | 376 (58.8) |
| Chronic kidney disease, n(%) | 43 (8.2) | 81 (14.0) | 12 (3.8) | 31 (4.8) |
| Smoking history, n(%) | 227 (43.2) | 162 (28.4) | 208 (66.7) | 270 (42.7) |
| Anti-HTN medication use, n(%) | 252 (48) | 276 (48) | 146 (47) | 320 (50) |
| Systolic blood pressure, mmHg | 126 ±18 | 122±21 | 130±19 | 128±22 |
| Diastolic blood pressure, mmHg | 74±10 | 67±10 | 76±12 | 72±10 |
| Body-mass index, kg/m2 | 29±5 | 30±7 | 30±6 | 33±8 |
| GFR, ml/min/1.73 m2 | 81±17 | 76±16 | 95±21 | 93±21 |
| Fasting glucose, mg/dl | 103±28 | 101±39 | 108±51 | 108±48 |
| Total cholesterol, mg/dl | 191±37 | 201±39 | 194±42 | 196±39 |
| HDL cholesterol, mg/dl | 42±10 | 53±15 | 50±15 | 56±15 |
| Triglyceride, mg/dl | 142 (99–205) | 140 (95–203) | 93 (68–131) | 89 (64–127) |
| LDL cholesterol, mg/dl | 116±32 | 117±34 | 122±40 | 120±35 |
GFR = glomerular filtration rate; HTN = hypertension; HDL = high-density lipoprotein; LDL = low-density lipoprotein